New Study Uncovers Pharmaceutical Medical Affair's Best Practices


RESEARCH TRIANGLE PARK, NC--(Marketwire - March 12, 2008) - A study released by Cutting Edge Information finds that the reporting structure of many pharmaceutical medical affairs departments has shifted away from marketing oversight in response to pressures related to compliance. CEI data show that in 2002, 43% of medical affairs departments were housed under marketing; this percentage has fallen to 7% in 2008.

The report, "Medical Affairs: Delivering Strategic Value," examines pharmaceutical companies' medical affairs structures, spending and staffing resources, and strategies in response to today's compliance-driven, global environment (www.pharmamedicalaffairs.com).

"Through our research, we found that companies responded to the regulatory landscape in different ways. Regulatory guidelines have had a dramatic effect on how companies organize and support their medical affairs function -- as the change in reporting structures over the past six years indicates," said Amanda Zuniga, lead author of the report. "Companies are extremely aware of the need to stay compliant and they have learned to adjust. The most progressive companies have even used the regulatory changes as a springboard for growth and reexamination."

Findings provide benchmarks to help companies improve the efficiency of their medical affairs efforts. Research covers the following highlights:

--  Surveyed companies' decision-making processes regarding medical
    affairs structure and internal alignment
--  The effect of globalization on companies' medical affairs practices
--  Medical affairs departments' sources of funding
--  Benchmarks for spending levels for various medical affairs activities,
    such as thought leader development, MSL programs, medical publications,
    medical education, medical information, and investigator-initiated trials
--  Measure of impact that various regulations have had on companies'
    operations
    

Based on interviews with industry executives, the report provides several best practices, which detail how leading companies adapt and thrive commercially while still remaining compliant. The study offers strategies for how medical affairs teams can improve internal communication and coordination, as well as negotiate effectively for additional resources.

Download a free summary of "Medical Affairs: Delivering Strategic Value" or purchase the report at: http://www.cuttingedgeinfo.com/pharmamedicalaffairs/PH112_Download.asp#body.

Contact Information: CONTACT: Amanda Zuniga 919-433-0210